Magnus Financial Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Magnus Financial Group LLC

$882 Million
Q2 2024

A detailed history of Magnus Financial Group LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Magnus Financial Group LLC holds 1,568 shares of REGN stock, worth $1.63 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

1,568

Previous 1,567 0.06%

Holding current value

$1.63 Million

Previous $1.51 Million 9.28%

% of portfolio

0.19%

Previous 0.18%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$883.2 - $1071.19 $883 - $1,071	1 Added 0.06%	1,568 $1.65 Million
Q1 2024 May 03, 2024	BUY	$902.69 - $993.35 $7,221 - $7,946	8 Added 0.51%	1,567 $1.51 Million
Q4 2023 Feb 05, 2024	BUY	$775.18 - $881.7 $2,325 - $2,645	3 Added 0.19%	1,559 $1.37 Million
Q3 2023 Oct 10, 2023	BUY	$692.45 - $844.37 $103,867 - $126,655	150 Added 10.67%	1,556 $1.28 Million
Q2 2023 Jul 19, 2023	SELL	$700.03 - $830.35 $77,003 - $91,338	-110 Reduced 7.26%	1,406 $1.01 Million
Q1 2023 May 10, 2023	BUY	$680.49 - $826.97 $10,207 - $12,404	15 Added 1.0%	1,516 $1.25 Million
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $4,235 - $4,598	-6 Reduced 0.4%	1,501 $1.08 Million
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $282,393 - $356,365	492 Added 48.47%	1,507 $1.04 Million
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $8,773 - $11,821	16 Added 1.6%	1,015 $600,000
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $8,331 - $9,778	14 Added 1.42%	999 $698,000
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $20,108 - $24,825	37 Added 3.9%	985 $622,000
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $20,091 - $23,833	35 Added 3.83%	948 $574,000
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $80,376 - $94,951	170 Added 22.88%	913 $510,000
Q1 2021 May 05, 2021	SELL	$446.73 - $548.2 $90,239 - $110,736	-202 Reduced 21.38%	743 $352,000
Q4 2020 Feb 05, 2021	SELL	$478.3 - $607.98 $297,502 - $378,163	-622 Reduced 39.69%	945 $457,000
Q3 2020 Nov 05, 2020	SELL	$544.75 - $658.21 $58,288 - $70,428	-107 Reduced 6.39%	1,567 $877,000
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $342,364 - $446,880	694 Added 70.82%	1,674 $1.04 Million
Q1 2020 May 11, 2020	SELL	$336.18 - $494.43 $108,249 - $159,206	-322 Reduced 24.73%	980 $479,000
Q4 2019 Jan 28, 2020	BUY	$274.13 - $376.51 $356,917 - $490,216	1,302 New	1,302 $489,000
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $379,015 - $441,288	-1,386 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$299.6 - $414.82 $144,407 - $199,943	482 Added 53.32%	1,386 $434,000
Q1 2019 May 09, 2019	BUY	$372.08 - $439.57 $6,697 - $7,912	18 Added 2.03%	904 $371,000
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $297,536 - $357,093	886 New	886 $331,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Magnus Financial Group LLC with notifications on news.

Account

Magnus Financial Group LLC Regeneron Pharmaceuticals, Inc. Transaction History